Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
Revenue
Bio Rad Laboratories Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio Rad Laboratories Inc
NYSE:BIO
|
Revenue
$2.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Bio Rad Laboratories Inc
Revenue Breakdown
Breakdown by Geography
Bio Rad Laboratories Inc
Total Revenue:
2.7B
USD
|
United States:
1.1B
USD
|
Europe:
819.8m
USD
|
Asia:
563m
USD
|
Other (Primarily Canada And Latin America):
166.6m
USD
|
Breakdown by Segments
Bio Rad Laboratories Inc
Total Revenue:
2.7B
USD
|
Clinical Diagnostics:
1.5B
USD
|
Life Science:
1.2B
USD
|
All Other Segments:
3.6m
USD
|
See Also
What is Bio Rad Laboratories Inc's Revenue?
Revenue
2.7B
USD
Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Revenue amounts to 2.7B USD.
What is Bio Rad Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Bio Rad Laboratories Inc have been 2% over the past three years , 3% over the past five years , and 2% over the past ten years .